Longboard Pharmaceuticals Competitors and Similar CompaniesClear all
Longboard Pharmaceuticals's competitors and similar companies include Autolus and Aurealis Therapeutics.
 Longboard Pharmaceuticals Longboard Pharmaceuticals, Inc. (Longboard) is a biopharmaceutical company focused on developing transformative medicines for neurological diseases. |  Autolus Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products. |  Aurealis Therapeutics Aurealis Therapeutics (formerly known as Aurealis Pharma) is a biopharmaceutical company developing medicines for the treatment of cancer and chronic wounds. | |
Founding Date | Founding Date 2020 | Founding Date 2014 | Founding Date 2010 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations San Diego, US HQ San Diego, US | Locations London, GB HQ London, GB | Locations Basel, CH HQ Kuopio, FI |
Employees | Employees 5056% increase | Employees 647 | Employees 18 |
Valuation ($) | Valuation ($) 2.3 b | Valuation ($) 1.2 b | Valuation ($) N/A |
Financial | |||
Net income | Net income ($54.4m) (FY, 2023) | Net income ($287.5m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 56m | Total funding raised $ 281.7m | Total funding raised $ 5.7m |
For sources of this data, please see the company profile
View Company Profiles
Autolus
HQ
London, GB
Employees
647
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
View companyAurealis Therapeutics
HQ
Basel, CH
Employees
18
Aurealis Therapeutics (formerly known as Aurealis Pharma) is a biopharmaceutical company developing medicines for the treatment of cancer and chronic wounds.
View company